Price target
13.820.00 0.00%
The 11 analysts offering 1 year price forecasts for BCRX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 12 analysts giving stock ratings to BCRX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BCRX EPS for the last quarter is −0.31 USD despite the estimation of −0.25 USD. In the next quarter EPS is expected to reach −0.21 USD. Track more of BioCryst Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter BioCryst Pharmaceuticals, Inc. revenue is expected to reach 85.62 M USD. Check out BioCryst Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, BCRX price target is 13.82 USD with a max estimate of 30.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch BioCryst Pharmaceuticals, Inc. stock price chart and keep track of the current situation with BCRX news and stock market news.
We've gathered opinions of 12 analysts rating BCRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.